Sign inJoin waitlistJoin the waitlist

Premal Thaker

Chief, Gynecologic Oncology · Washington University/B-JH/SLCH Consortium

Credentials: · · · · · · ·

History

Gynecologic Oncology Division · Washington University/B-JH/SLCH Consortium
Present
Gynecologic Oncology Clinical Research · Washington University/B-JH/SLCH Consortium
Present
Washington University/B-JH/SLCH Consortium
Present

Gynecologic Oncology
2005–2008
Obstetrics and Gynecology
2001–2005
Allegheny University Of The Health Sciences
1993–1997

Research

Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
Nature Medicine · 2006 · First of 27 authors · 1,063 citations
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
New England Journal of Medicine · 2023 · 633 citations
Stress hormone-mediated invasion of ovarian cancer cells
Clinical Cancer Research · 2006 · 408 citations

David Mutch
100 papers
Matthew Powell
98 papers
Andrea Hagemann
61 papers · 14 as a fellow
Lindsay Kuroki
49 papers · 27 as a resident
SM
Stewart Massad
48 papers
Anil Sood
42 papers
Carolyn McCourt
40 papers
Katherine Fuh
35 papers
MM
Mary Mullen
29 papers · 20 as a resident
Michael Goodheart
25 papers
Israel Zighelboim
22 papers · 19 as a fellow
Kathleen Moore
18 papers

Grants

Washington University / Siteman Cancer Center Lead Academic Site
National Cancer Institute · UG1
PI · $11.3M · Washington University
2019–2032
SPORE in Endometrial Cancer
National Cancer Institute · P50
Project lead · $93.4K · Washington University
2009–2012

Clinical trials

Identification and Prevention of Pelvic Floor Dysfunction in Gynecologic Cancer Survivors
Principal investigator · Terminated
Washington University School of Medicine
2023–2025
Comparing Intrathecal Morphine and Intraoperative Lidocaine Infusion to Epidural Anesthesia With Postoperative PCA for Patients Undergoing Exploratory Laparotomy
Principal investigator · Terminated · Phase 2
Washington University School of Medicine
2022–2024
MK-3475 Immunotherapy in Endometrial Carcinoma
Principal investigator · Completed · Phase 1
Washington University School of Medicine
2016–2020
EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Principal investigator · Completed · Phase 1
Gynecologic Oncology Group
2012–2018